MAD2L2 and lung cancer: Potential mechanisms by which MAD2L2 rs746218 and TNFRSF1A rs4149570 impacted prognosis in patients with lung cancer who received platinum-based chemotherapy were determined using TCGA data (https://portal.gdc.cancer.gov/).